Pulmonary Disease Doctors in Park Ridge, IL Accepting Medicare

4 Pulmonary Disease doctors found. Showing 1 - 4

Mohammed Omer Ahmed Abdalla, Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 850 Busse Hwy, Park Ridge, IL 60068 Phone: 847-759-4770

Elizabeth Mary Klein, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 850 Busse Hwy, Park Ridge, IL 60068 Phone: 847-759-4770    Fax: 847-759-8824

Dr. Farhan Zaidi, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 444 N Northwest Hwy Ste 206, Park Ridge, IL 60068 Phone: 847-653-6184    Fax: 847-696-7932

Bhaven Shah, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 850 Busse Hwy, Park Ridge, IL 60068 Phone: 847-759-4770

News Archive

Parents who force kids to apologize before they are truly sorry may do more harm than good

Parents who force unremorseful kids to apologize to others before they're truly sorry may do more harm than good.

UTSA to implement Click Commerce eResearch Portal software

Click Commerce announced today that the University of Texas at San Antonio (UTSA) will use the company's eResearch Portal software to fully automate a variety of research administration and compliance processes, including those associated with Institutional Review Board (IRB), Institutional Animal Care and Use Committee (IACUC), and Conflict of Interest (COI).

Measles deaths decline worldwide by 78%, experts warn against complacency

Measles deaths fell from 733,000 in 2000 to 164,000 in 2008 - 78 percent - thanks, in part, to increased vaccination efforts that reached an estimated 700 million children, according to a report released Thursday by the U.S.-based Measles Initiative, Reuters reports.

Household income level not associated with intellectual disability or ASD, finds new study

New research from the University of Utah in collaboration with the Utah Department of Health (UDOH) shows that the presence or absence of intellectual disability (ID) and autism spectrum disorders (ASD) varies with risk factors such as gender, parental age, maternal ethnicity, and maternal level of education.

Two Phase 3 studies of Sutent in advanced breast cancer fail to meet primary endpoints

Pfizer Inc. announced today that two Phase 3 studies of Sutent® (sunitinib malate) in advanced breast cancer did not meet their primary endpoints. The SUN 1064 Phase 3 study of sunitinib in combination with docetaxel for the first-line treatment of patients with advanced HER-2 negative breast cancer did not show a statistically significant improvement in progression-free survival compared with docetaxel alone.

Read more Medical News

› Verified 6 days ago